INOVIS presents
CYP ROUNDTABLE
Rethinking the Role of Competitive Intelligence - What is your experience?
- How has pharma CI evolved since the 1990s (i.e. CI-evolution)?
- How it changed and how does it differs between small-, mid-, and large-size companies?
- What is the aspiration of the CI industry?
- What are and have been the drivers and restrictors?
- What are the key enablers to achieve the aspiration?
Baljit Singh
Managing Director & Partner, INOVIS